New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Neoscriber Demo Publisher

Early and Midterm Major Adverse Cardiac Events in Patient With Saphenous Vein Graft Using Direct Stenting or Embolic Protection Device Stenting

Mohammadali Sadr-Ameli 1 , Hossein Mousavi 2 , Mona Heidarali 1 , Mohsen Madaani 3 , * , Yones Ghelich 4 and Behshid Ghadrdoost 2
Authors Information
1 Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
2 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
3 Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Intervention, 502 Military Hospital, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: February 27, 2014, 3 (1); e13012
  • Published Online: February 27, 2014
  • Article Type: Research Article
  • Received: June 17, 2013
  • Revised: August 24, 2013
  • Accepted: November 15, 2013
  • DOI: 10.5812/cardiovascmed.13012

To Cite: Sadr-Ameli M, Mousavi H, Heidarali M, Madaani M, Ghelich Y, et al. Early and Midterm Major Adverse Cardiac Events in Patient With Saphenous Vein Graft Using Direct Stenting or Embolic Protection Device Stenting, Res Cardiovasc Med. 2014 ;3(1):e13012. doi: 10.5812/cardiovascmed.13012.

Abstract
Copyright: Copyright © 0, Research in Cardiovascular Medicine. .
1. Introduction
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Grow P, Rab ST. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device. Catheter Cardiovasc Interv. 2008; 72(5): 636-40[DOI][PubMed]
  • 2. Hernandez-Antolin R, Alfonso F, Jimenez P. The use of drug-eluting stents in venous coronary artery bypass grafts. EuroIntervention. 2009; 5 Suppl D-7[PubMed]
  • 3. Heuser RR, Ly S, Assar SM. An overview of modern embolic protection in percutaneous coronary intervention. Indian Heart J. 2008; 60(2): 91-4[PubMed]
  • 4. Maia F, Costa JR, Jr, Abizaid A, Feres F, Costa R, Staico R, et al. Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization. Catheter Cardiovasc Interv. 2010; 76(1): 86-92[DOI][PubMed]
  • 5. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008; 117(6): 790-7[DOI][PubMed]
  • 6. Burzotta F, Testa L, Giannico F, Biondi-Zoccai GG, Trani C, Romagnoli E, et al. Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trials. Int J Cardiol. 2008; 123(3): 313-21[DOI][PubMed]
  • 7. Okabe T, Lindsay J, Torguson R, Steinberg DH, Roy P, Slottow TL, et al. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv. 2008; 72(6): 799-803[DOI][PubMed]
  • 8. van Gaal WJ, Choudhury RP, Porto I, Channon K, Banning A, Dzavik V, et al. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol. 2007; 99(5): 603-6[DOI][PubMed]
  • 9. Lavi S, Ivanov J, Appleby CE, Seidelin PH, Mackie K, Schwartz L, et al. Selective use of embolic protection devices during saphenous vein grafts interventions: a single-center experience. Catheter Cardiovasc Interv. 2010; 75(7): 1037-44[DOI][PubMed]
  • 10. Kirtane AJ, Heyman ER, Metzger C, Breall JA, Carrozza JP, Jr. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy. JACC Cardiovasc Interv. 2008; 1(2): 186-91[DOI][PubMed]
  • 11. Nair S, Fath-Ordoubadi F, Clarke B, El-Omar M, Foley J, Fraser DG, et al. Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention. EuroIntervention. 2011; 6(8): 985-91[DOI][PubMed]
  • 12. Lupi A, Navarese EP, Lazzero M, Sansa M, De Servi S, Serra A, et al. Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. Circ J. 2011; 75(2): 280-9[PubMed]
  • 13. Abbo KM, Dooris M, Glazier S, O'Neill WW, Byrd D, Grines CL, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol. 1995; 75(12): 778-82[PubMed]
  • 14. Waksman R, Douglas JS, Jr., Scott NA, Ghazzal ZM, Yee-Peterson J, King SB, 3rd. Distal embolization is common after directional atherectomy in coronary arteries and saphenous vein grafts. Am Heart J. 1995; 129(3): 430-5[PubMed]
  • 15. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000; 101(5): 570-80[PubMed]
  • 16. Baim DS, Carrozza JP, Jr. Understanding the "no-reflow" problem. Cathet Cardiovasc Diagn. 1996; 39(1): 7-8[DOI][PubMed]
  • 17. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation. 1994; 89(6): 2514-8[PubMed]
  • 18. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999; 100(24): 2400-5[PubMed]
  • 19. Cohen DJ, Murphy SA, Baim DS, Lavelle TA, Berezin RH, Cutlip DE, et al. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol. 2004; 44(9): 1801-8[DOI][PubMed]
  • 20. Lefkovits J, Holmes DR, Califf RM, Safian RD, Pieper K, Keeler G, et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation. 1995; 92(4): 734-40[PubMed]
  • 21. Waksman R, Weintraub WS, Ghazzal Z, Scott NA, Shen Y, King SB, 3rd, et al. Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. Am Heart J. 1997; 134(2 Pt 1): 274-81[PubMed]
  • 22. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002; 105(11): 1285-90[PubMed]
  • 23. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003; 108(5): 548-53[DOI][PubMed]
  • 24. Mauri L, Rogers C, Baim DS. Devices for distal protection during percutaneous coronary revascularization. Circulation. 2006; 113(22): 2651-6[DOI][PubMed]
  • 25. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky A, Kent KM, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol. 2001; 38(1): 150-4[PubMed]
  • 26. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001; 38(3): 659-65[PubMed]
  • 27. Platko WP, Hollman J, Whitlow PL, Franco I. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up. J Am Coll Cardiol. 1989; 14(7): 1645-50[PubMed]
  • 28. Cote G, Myler RK, Stertzer SH, Clark DA, Fishman-Rosen J, Murphy M, et al. Percutaneous transluminal angioplasty of stenotic coronary artery bypass grafts: 5 years' experience. J Am Coll Cardiol. 1987; 9(1): 8-17[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader